Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
Annals of Clinical Biochemistry
|
February 8, 2021
Evaluation of the MP Rapid 2019-NCOV IgM/IgG combo POCT test vs. an established platform-based method
N Jassam, J H Barth, V Allgar, et al.
Diabetes, Obesity & Metabolism
|
December 4, 2025
Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus
Yun Wang, Sihe Wang, Wei Wang, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2022
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control study
Julie Settles, Hong Kan, Christopher J Child, et al.
The New England Journal of Medicine
|
June 23, 2025
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Julio Rosenstock, Timothy Bailey, Lisa Connery, et al.
CMAJ Open
|
September 12, 2018
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study
Cheri Deal, Susan Kirsch, Jean-Pierre Chanoine, et al.
Journal of Assisted Reproduction and Genetics
|
April 23, 2005
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment
Seang Lin Tan, Timothy J Child, Anthony P Cheung, et al.
Journal of the American College of Cardiology
|
August 1, 1996
Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure
W S McMahon, H H Holzgrefe, J D Walker, et al.
European Journal of Endocrinology
|
January 30, 2013
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS
Whitney W Woodmansee, Alan G Zimmermann, Christopher J Child, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
Frank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2004
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients
Andrea F Attanasio, Elena Shavrikova, Werner F Blum, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
Annals of Clinical Biochemistry
|
February 8, 2021
Evaluation of the MP Rapid 2019-NCOV IgM/IgG combo POCT test vs. an established platform-based method
N Jassam, J H Barth, V Allgar, et al.
Diabetes, Obesity & Metabolism
|
December 4, 2025
Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus
Yun Wang, Sihe Wang, Wei Wang, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2022
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control study
Julie Settles, Hong Kan, Christopher J Child, et al.
The New England Journal of Medicine
|
June 23, 2025
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Julio Rosenstock, Timothy Bailey, Lisa Connery, et al.
CMAJ Open
|
September 12, 2018
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study
Cheri Deal, Susan Kirsch, Jean-Pierre Chanoine, et al.
Journal of Assisted Reproduction and Genetics
|
April 23, 2005
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment
Seang Lin Tan, Timothy J Child, Anthony P Cheung, et al.
Journal of the American College of Cardiology
|
August 1, 1996
Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure
W S McMahon, H H Holzgrefe, J D Walker, et al.
European Journal of Endocrinology
|
January 30, 2013
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS
Whitney W Woodmansee, Alan G Zimmermann, Christopher J Child, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
Frank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2004
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients
Andrea F Attanasio, Elena Shavrikova, Werner F Blum, et al.
Page
of 19